These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 27989076)

  • 21. Effect of SDS-based decelullarization in the prevention of calcification in glutaraldehyde-preserved bovine pericardium: study in rats.
    Collatusso C; Roderjan JG; Vieira ED; Costa FD; Noronha Ld; Fornazari Dde F
    Rev Bras Cir Cardiovasc; 2012; 27(1):88-96. PubMed ID: 22729305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Durable Porcine Pericardial Surgical Bioprosthetic Heart Valve: a Proof of Concept.
    Rahmani B; McGregor C; Byrne G; Burriesci G
    J Cardiovasc Transl Res; 2019 Aug; 12(4):331-337. PubMed ID: 30756359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
    Neethling WM; Hodge AJ; Clode P; Glancy R
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between the alpha-Gal antigen, antibody response and calcification of cardiac valve bioprostheses: experimental evidence obtained using an alpha-Gal knockout mouse animal model.
    Naso F; Colli A; Zilla P; Calafiore AM; Lotan C; Padalino MA; Sturaro G; Gandaglia A; Spina M
    Front Immunol; 2023; 14():1210098. PubMed ID: 37426661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-Gal specific IgG immune response after implantation of bioprostheses.
    Mangold A; Szerafin T; Hoetzenecker K; Hacker S; Lichtenauer M; Niederpold T; Nickl S; Dworschak M; Blumer R; Auer J; Ankersmit HJ
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):191-5. PubMed ID: 19670109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of glutaraldehyde concentration and fixation time on material characteristics and calcification of bovine pericardium: implications for the optimal method of fixation of autologous pericardium used for cardiovascular surgery.
    Lee C; Lim HG; Lee CH; Kim YJ
    Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):402-406. PubMed ID: 28011740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.
    Lim HG; Kim GB; Jeong S; Kim YJ
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):104-13. PubMed ID: 25315752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
    Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
    Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification.
    Abolhoda A; Yu S; Oyarzun JR; McCormick JR; Bogden JD; Gabbay S
    Ann Thorac Surg; 1996 Jul; 62(1):169-74. PubMed ID: 8678638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti alpha-gal immune response following porcine bioprosthesis implantation in children.
    Park CS; Park SS; Choi SY; Yoon SH; Kim WH; Kim YJ
    J Heart Valve Dis; 2010 Jan; 19(1):124-30. PubMed ID: 20329498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
    Zhou J; Jiang H; Wang D; Hu S
    J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies.
    Ramm R; Niemann H; Petersen B; Haverich A; Hilfiker A
    Basic Res Cardiol; 2016 Jul; 111(4):39. PubMed ID: 27154491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-Gal Inactivated Heart Valve Bioprostheses Exhibit an Anti-Calcification Propensity Similar to Knockout Tissues.
    Naso F; Stefanelli U; Buratto E; Lazzari G; Perota A; Galli C; Gandaglia A
    Tissue Eng Part A; 2017 Oct; 23(19-20):1181-1195. PubMed ID: 29053434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donkey pericardium as an alternative bioprosthetic heart valve material.
    Chen S; Xu L; Liu Y; Li Q; Wang D; Wang X; Liu T
    Artif Organs; 2013 Mar; 37(3):248-55. PubMed ID: 23145868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The α-Gal KO Mouse Animal Model is a Reliable and Predictive Tool for the Immune-Mediated Calcification Assessment of Heart Valve Bioprostheses.
    Naso F; Gandaglia A; Sturaro G; Galli C; Melder RJ
    Front Biosci (Landmark Ed); 2024 May; 29(5):181. PubMed ID: 38812319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro properties and performance of glutaraldehyde-crosslinked bovine pericardial bioprostheses treated with glutamic acid.
    Braile MC; Carnevalli NC; Goissis G; Ramirez VA; Braile DM
    Artif Organs; 2011 May; 35(5):497-501. PubMed ID: 21595718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degenerative Calcification of Pericardial Bioprostheses: Comparison of Five Implantation Methods in a Rabbit Model.
    Kim DH; Park HK; Park YH; Lee SH; Joo HC; Lee S; Youn YN; Shin HJ
    J Heart Valve Dis; 2015 Sep; 24(5):621-8. PubMed ID: 26897842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amide cross-linking: an alternative to glutaraldehyde fixation.
    Girardot JM; Girardot MN
    J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stentless valves treated by the L-hydro process in the aortic position in sheep.
    Santos PC; Gerola LR; Casagrande I; Buffolo E; Cheung DT
    Asian Cardiovasc Thorac Ann; 2007 Oct; 15(5):413-7. PubMed ID: 17911070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.
    Manji RA; Menkis AH; Cooper DK
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):238-9; author reply 239. PubMed ID: 21683844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.